CTT PHARMACEUTICAL HOLDINGS, INC.
CEO
CTT PHARMACEUTICAL HOLDINGS, INC. has filed 21 SEC Form 4 filings (22 transaction rows) across 1 company, with disclosures dating back to 2025. 19 of those filings fall inside the rolling window. Most recent filing: Oct 19, 2026.
On the most recent filing, CTT PHARMACEUTICAL HOLDINGS, INC. is listed as CEO at CTT PHARMACEUTICAL HOLDINGS, INC. Inside the rolling window, CTT PHARMACEUTICAL HOLDINGS, INC. reported 17 open-market purchases totaling $16K in CTTH and no open-market sales. The largest disclosed transaction in the window is a purchase of 262,900 CTTH shares on Nov 20, 2025, worth $11K.
Companies traded
Insider Buying
$16K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CTTH | CEO | Purchase | 2,000 | $114 | Oct 19 | SEC ↗ | |
| CTTH | CEO | Purchase | 3,700 | $204 | Oct 6 | SEC ↗ | |
| CTTH | CEO | Purchase | 10,100 | $455 | Sep 29 | SEC ↗ | |
| CTTH | CEO | Purchase | 3,400 | $187 | Sep 28 | SEC ↗ | |
| CTTH | CEO | Purchase | 10,900 | $523 | Sep 16 | SEC ↗ | |
| CTTH | CEO | Purchase | 3,500 | $175 | Sep 10 | SEC ↗ | |
| CTTH | CEO | Purchase | 9,800 | $479 | Sep 4 | SEC ↗ | |
| CTTH | CEO | Purchase | 3,000 | $147 | Sep 2 | SEC ↗ | |
| CTTH | CEO | Purchase | 3,500 | $172 | Aug 31 | SEC ↗ | |
| CTTH | CEO | Purchase | 2,100 | $116 | Aug 25 | SEC ↗ | |
| CTTH | CEO | Purchase | 11,500 | $518 | Aug 20 | SEC ↗ | |
| CTTH | CEO | Purchase | 10,000 | $590 | Aug 19 | SEC ↗ | |
| CTTH | CEO | Purchase | 1,800 | $112 | Aug 14 | SEC ↗ | |
| CTTH | CEO | Purchase | 7,700 | $501 | Aug 10 | SEC ↗ | |
| CTTH | CEO | Purchase | 8,300 | $457 | Dec 17 | SEC ↗ | |
| CTTH | Director | Purchase | 262,900 | $11K | Nov 24 | SEC ↗ | |
| CTTH | CEO | Purchase | 7,000 | $420 | Oct 31 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has CTT PHARMACEUTICAL HOLDINGS, INC. made?
CTT PHARMACEUTICAL HOLDINGS, INC. has filed 21 SEC Form 4 filings (22 transaction rows) across 1 company since 2025.
Which companies does CTT PHARMACEUTICAL HOLDINGS, INC. trade?
CTT PHARMACEUTICAL HOLDINGS, INC. has filed SEC Form 4 disclosures for 1 company, including CTTH.
When was CTT PHARMACEUTICAL HOLDINGS, INC.'s most recent SEC Form 4 filing?
CTT PHARMACEUTICAL HOLDINGS, INC.'s most recent SEC Form 4 filing on Tracefour is dated Oct 19, 2026.
What is CTT PHARMACEUTICAL HOLDINGS, INC.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, CTT PHARMACEUTICAL HOLDINGS, INC. is listed as CEO.
What is CTT PHARMACEUTICAL HOLDINGS, INC.'s total buy and sell value in the current window?
Inside the rolling retention window, CTT PHARMACEUTICAL HOLDINGS, INC. bought $16K and sold $0 based on SEC Form 4 filings.
What was CTT PHARMACEUTICAL HOLDINGS, INC.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 262,900 CTTH shares on 2025-11-20, worth $11K, per SEC Form 4 filings.